Regeneron Pharmaceuticals (REGN) Shares Issued (2009 - 2026)

Regeneron Pharmaceuticals' Shares Issued history runs 18 years deep, the most recent figure standing at $163.1 million for Q1 2026.

• In Q1 2026, Shares Issued rose 169.14% year-over-year to $163.1 million; the TTM figure through Mar 2026 stood at $738.4 million (down 12.49% YoY), while the FY2025 annual figure was $635.9 million, down 56.6% from the prior year.
• Shares Issued was $163.1 million for Q1 2026 at Regeneron Pharmaceuticals, down from $503.5 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $682.1 million in Q1 2024 to a low of $31.5 million in Q2 2025.
• Historically, Shares Issued has averaged $290.0 million across 5 years, with a median of $301.0 million in 2023.
• Biggest YoY gain for Shares Issued was 453.91% in 2025; the steepest drop was 92.8% in 2025.
• A 5-year view of Shares Issued shows it stood at $372.6 million in 2022, then fell by 19.22% to $301.0 million in 2023, then slumped by 69.8% to $90.9 million in 2024, then surged by 453.91% to $503.5 million in 2025, then slumped by 67.61% to $163.1 million in 2026.
• The last three Shares Issued figures came in at $163.1 million (Q1 2026), $503.5 million (Q4 2025), and $40.3 million (Q3 2025), per Business Quant data.